US5981165A
(en)
*
|
1991-07-08 |
1999-11-09 |
Neurospheres Holdings Ltd. |
In vitro induction of dopaminergic cells
|
WO1995006662A1
(en)
*
|
1993-09-01 |
1995-03-09 |
Start Technology Partnership |
Neuron regulatory factor for promoting neuron survival
|
AU1443095A
(en)
*
|
1993-12-22 |
1995-07-10 |
University Of Medicine And Dentistry Of New Jersey |
Novel nucleic acid sequences isolated from glial cells
|
US6472585B1
(en)
|
1994-04-25 |
2002-10-29 |
Genentech, Inc. |
Cardiotrophin-1 defective mouse
|
US7258983B2
(en)
|
1994-04-25 |
2007-08-21 |
Genentech, Inc. |
Cardiotrophin-1 compositions and methods for the treatment of tumor
|
US5534615A
(en)
*
|
1994-04-25 |
1996-07-09 |
Genentech, Inc. |
Cardiac hypertrophy factor and uses therefor
|
JP3906314B2
(ja)
*
|
1994-04-25 |
2007-04-18 |
ジェネンテク・インコーポレイテッド |
カルジオトロフィンおよびその使用
|
US5853385A
(en)
*
|
1994-08-26 |
1998-12-29 |
Cytotherapeutics, Inc. |
Encapsulated PC12 cell transplants for treatment of Parkinson's disease
|
US5733875A
(en)
*
|
1994-11-15 |
1998-03-31 |
Amgen Inc. |
Methods of using GDNF as a neuroprotective agent
|
JP3093974B2
(ja)
*
|
1995-06-27 |
2000-10-03 |
住友ベークライト株式会社 |
神経細胞用培養液、その製造方法及びこれを用いる神経細胞の培養方法
|
US6743628B1
(en)
|
1995-08-28 |
2004-06-01 |
Washington University |
Method of cell culture using neurturin
|
US5739307A
(en)
*
|
1995-08-28 |
1998-04-14 |
Washington University |
Polynucleotide encoding neurturin neurotrophic factor
|
US5731284A
(en)
*
|
1995-09-28 |
1998-03-24 |
Amgen Inc. |
Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
|
US6184200B1
(en)
*
|
1995-09-28 |
2001-02-06 |
Amgen Inc. |
Truncated glial cell line-derived neurotrophic factor
|
US5641749A
(en)
*
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
|
US5641750A
(en)
*
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
|
AU1121997A
(en)
*
|
1995-11-29 |
1997-06-19 |
Amgen, Inc. |
Method for treating sensory neuropathy using glial cell line-derived neurotrophic factor (gdnf) protein product
|
US5905027A
(en)
*
|
1995-12-27 |
1999-05-18 |
Uab Research Foundation |
Method of diagnosing and treating gliomas
|
US5837681A
(en)
*
|
1996-02-23 |
1998-11-17 |
Amgen Inc. |
Method for treating sensorineural hearing loss using glial cell line-derived neurotrophic factor (GDNF) protein product
|
US5929041A
(en)
*
|
1996-02-23 |
1999-07-27 |
Amgen Inc. |
Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product
|
JP4301347B2
(ja)
|
1996-03-14 |
2009-07-22 |
ジェネンテク, インコーポレイテッド |
Gdnfおよびgdnf受容体の用途
|
US6222022B1
(en)
|
1996-03-14 |
2001-04-24 |
Washington University |
Persephin and related growth factors
|
US6716600B1
(en)
|
1996-03-14 |
2004-04-06 |
Washington University |
Persephin and related growth factors
|
ES2237793T3
(es)
|
1996-03-14 |
2005-08-01 |
Washington University |
Persefina y factores de crecimiento relacionados.
|
US5741778A
(en)
*
|
1996-03-19 |
1998-04-21 |
Amgen Inc. |
Method for treating Huntington's disease using glial cell line-derived neurotrophic factor (GDNF) protein product
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
US6455277B1
(en)
*
|
1996-04-22 |
2002-09-24 |
Amgen Inc. |
Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides
|
US7138251B1
(en)
|
1996-04-22 |
2006-11-21 |
Amgen Inc. |
Polynucleotides encoding a neurotrophic factor receptor
|
AU2677797A
(en)
*
|
1996-04-25 |
1997-11-12 |
Genetic Therapy, Inc. |
Viral vectors including polynucleotides encoding neurotrophic factors and uses therefor
|
EP0922101B1
(en)
*
|
1996-07-29 |
2003-12-17 |
BIOPHARM Gesellschaft zur biotechnologischen Entwicklung und zum Vertrieb von Pharmaka mbH |
Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons
|
ES2308800T3
(es)
|
1997-01-08 |
2008-12-01 |
Invitrogen Corporation |
Metodos para la produccion de proteinas.
|
US6777196B2
(en)
|
1997-02-18 |
2004-08-17 |
Genentech, Inc. |
Neurturin receptor
|
US6025157A
(en)
|
1997-02-18 |
2000-02-15 |
Genentech, Inc. |
Neurturin receptor
|
US6372453B1
(en)
|
1997-02-18 |
2002-04-16 |
Genetech, Inc. |
Neurturin receptor
|
US6042579A
(en)
*
|
1997-04-30 |
2000-03-28 |
Medtronic, Inc. |
Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain
|
US6043221A
(en)
*
|
1997-07-30 |
2000-03-28 |
Amgen Inc. |
Method for preventing and treating hearing loss using a neuturin protein product
|
EP1304119A3
(en)
*
|
1997-07-30 |
2004-01-21 |
Amgen Inc. |
Method for preventing and treating hearing loss using a neurturin protein product
|
DE69837600T2
(de)
*
|
1997-08-05 |
2007-12-27 |
F. Hoffmann-La Roche Ag |
Aus einer menschlichen glial zelllinie-abgeleiteter promotor eines neurotrophischen faktors, diesen enthaltende vektoren und methoden zum screenen von verbindungen damit
|
US7026138B1
(en)
|
1998-03-23 |
2006-04-11 |
Genentech, Inc. |
Polynucleotides encoding GFRα3
|
AU765070B2
(en)
|
1998-03-23 |
2003-09-11 |
Genentech Inc. |
GFRalpha3 and its uses
|
DE19816186A1
(de)
*
|
1998-04-14 |
1999-10-21 |
Univ Muenchen L Maximilians |
GDNF-kodierende DNA, Teile davon und GDNF-Varianten
|
US6593133B1
(en)
|
1998-07-06 |
2003-07-15 |
Nsgene A/S |
Neurotrophic factors
|
US6284540B1
(en)
*
|
1998-09-29 |
2001-09-04 |
Washington University |
Artemin, a novel neurotrophic factor
|
US7060676B2
(en)
|
1999-12-20 |
2006-06-13 |
Trustees Of Tufts College |
T. cruzi-derived neurotrophic agents and methods of use therefor
|
US20040014082A1
(en)
*
|
2000-08-11 |
2004-01-22 |
Invitrogen Corporation |
Highly homogeneous molecular markers for electrophoresis
|
US6426065B1
(en)
*
|
2000-11-07 |
2002-07-30 |
Clairol Incorporated |
Use of tris(hydroxymethyl)aminomethane in cold permanent waving processes
|
US7442370B2
(en)
|
2001-02-01 |
2008-10-28 |
Biogen Idec Ma Inc. |
Polymer conjugates of mutated neublastin
|
US7276580B2
(en)
|
2001-03-12 |
2007-10-02 |
Biogen Idec Ma Inc. |
Neurotrophic factors
|
AU2002250203B2
(en)
|
2001-03-28 |
2006-08-10 |
Biogen Ma Inc. |
Use of neublastin polypeptides for treating neuropathic pain
|
US20030050273A1
(en)
*
|
2001-08-29 |
2003-03-13 |
Keiya Ozawa |
Compositions and methods for treating neurodegenerative diseases
|
US7613491B2
(en)
*
|
2002-05-22 |
2009-11-03 |
Dexcom, Inc. |
Silicone based membranes for use in implantable glucose sensors
|
US8364229B2
(en)
*
|
2003-07-25 |
2013-01-29 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
JP2005526838A
(ja)
*
|
2002-04-25 |
2005-09-08 |
ウイスコンシン アラムナイ リサーチ フオンデーシヨン |
パーキンソン病および他の神経変性疾患を治療するためのgdnf分泌ヒト神経幹細胞の使用
|
US20060088899A1
(en)
*
|
2002-05-31 |
2006-04-27 |
Alvarez Vernon L |
Combination chemotherapy with chlorotoxin
|
US7528112B2
(en)
|
2002-11-15 |
2009-05-05 |
Drexel University |
Small survival-promoting/immunomodulatory peptide for treatment of brain damage, neurodegenerative disorders, and inflammatory disorders
|
US7388079B2
(en)
*
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
US20050048041A1
(en)
*
|
2003-01-13 |
2005-03-03 |
Rao Mahendra S. |
Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
|
KR20060002745A
(ko)
*
|
2003-01-13 |
2006-01-09 |
마헨드라 에스 라오 |
치료적 생성물의 전달을 위한 증식성 줄기세포 및전구세포에서의 후보 분자의 지속적 발현
|
US20040209810A1
(en)
*
|
2003-02-24 |
2004-10-21 |
Gill Steven S. |
Method of treating Parkinson's disease in humans by intraputaminal infusion of glial cell-line derived neurotrophic factor
|
US8946151B2
(en)
|
2003-02-24 |
2015-02-03 |
Northern Bristol N.H.S. Trust Frenchay Hospital |
Method of treating Parkinson's disease in humans by convection-enhanced infusion of glial cell-line derived neurotrophic factor to the putamen
|
CA2522364C
(en)
|
2003-04-18 |
2014-12-09 |
Biogen Idec Ma Inc. |
Polymer-conjugated glycosylated neublastin
|
US7875293B2
(en)
*
|
2003-05-21 |
2011-01-25 |
Dexcom, Inc. |
Biointerface membranes incorporating bioactive agents
|
WO2004108760A2
(en)
|
2003-06-10 |
2004-12-16 |
Nsgene A/S |
Improved secretion of neublastin
|
JP4708342B2
(ja)
*
|
2003-07-25 |
2011-06-22 |
デックスコム・インコーポレーテッド |
埋設可能な装置に用いる酸素増大膜システム
|
US9763609B2
(en)
|
2003-07-25 |
2017-09-19 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
US7591801B2
(en)
|
2004-02-26 |
2009-09-22 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US9135402B2
(en)
|
2007-12-17 |
2015-09-15 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US7920906B2
(en)
|
2005-03-10 |
2011-04-05 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
EP1662879A4
(en)
*
|
2003-08-29 |
2009-03-11 |
Univ New York |
INDIRECT ADMINISTRATION OF GROWTH FACTORS IN THE CENTRAL NERVOUS SYSTEM
|
US20060258576A1
(en)
*
|
2003-09-05 |
2006-11-16 |
Licentia, Ltd |
Gdnf-related neuropeptides
|
US7598059B2
(en)
|
2003-10-02 |
2009-10-06 |
Biogen Idec Ma Inc. |
Neublastin expression constructs
|
US20060239966A1
(en)
*
|
2003-10-20 |
2006-10-26 |
Tornoee Jens |
In vivo gene therapy of parkinson's disease
|
US9247900B2
(en)
|
2004-07-13 |
2016-02-02 |
Dexcom, Inc. |
Analyte sensor
|
US20050123526A1
(en)
*
|
2003-12-01 |
2005-06-09 |
Medtronic Inc. |
Administration of growth factors for neurogenesis and gliagenesis
|
US8093205B2
(en)
*
|
2003-12-01 |
2012-01-10 |
Medtronic, Inc. |
Method for treating a stroke by implanting a first therapy delivery element in the CNS and a second therapy delivery element in a damaged tissue of the CNS to promote neurogenesis
|
WO2005079257A2
(en)
*
|
2004-02-12 |
2005-09-01 |
Dexcom, Inc. |
Biointerface with macro- and micro- architecture
|
WO2009048462A1
(en)
|
2007-10-09 |
2009-04-16 |
Dexcom, Inc. |
Integrated insulin delivery system with continuous glucose sensor
|
US20050208090A1
(en)
*
|
2004-03-18 |
2005-09-22 |
Medtronic, Inc. |
Methods and systems for treatment of neurological diseases of the central nervous system
|
GB2414934A
(en)
*
|
2004-06-11 |
2005-12-14 |
Gill Steven Streatfield |
Treatment of Parkinson's disease with GDNF
|
CA2568150A1
(en)
*
|
2004-06-21 |
2006-01-05 |
Medtronic, Inc. |
Medical systems and methods for delivering compositions to cells
|
US20060020192A1
(en)
|
2004-07-13 |
2006-01-26 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
CA2577690C
(en)
|
2004-08-19 |
2013-08-06 |
Biogen Idec Ma Inc. |
Refolding transforming growth factor beta family proteins
|
SI1786454T1
(sl)
|
2004-08-19 |
2010-10-29 |
Biogen Idec Inc |
Variante neoblastina
|
US8133178B2
(en)
|
2006-02-22 |
2012-03-13 |
Dexcom, Inc. |
Analyte sensor
|
JP2009504689A
(ja)
*
|
2005-08-16 |
2009-02-05 |
ユニバーシティ オブ コペンハーゲン |
Gdnf由来ペプチド
|
US8124095B2
(en)
*
|
2005-10-07 |
2012-02-28 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of erythropoietin to the CNS
|
US8741260B2
(en)
*
|
2005-10-07 |
2014-06-03 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of GDNF to the CNS
|
US8053569B2
(en)
*
|
2005-10-07 |
2011-11-08 |
Armagen Technologies, Inc. |
Nucleic acids encoding and methods of producing fusion proteins
|
EP1940471A1
(en)
*
|
2005-10-28 |
2008-07-09 |
NsGene A/S |
IMPLANTABLE BIOCOMPATIBLE IMMtTNOISOLATORY VEHICLE FOR DELIVERY OF GDNF
|
PL1969003T3
(pl)
*
|
2005-12-14 |
2011-05-31 |
Herantis Pharma Plc |
Zastosowanie białka czynnika neurotroficznego
|
TWI501774B
(zh)
|
2006-02-27 |
2015-10-01 |
Biogen Idec Inc |
神經性病症之治療
|
WO2007120381A2
(en)
*
|
2006-04-14 |
2007-10-25 |
Dexcom, Inc. |
Analyte sensor
|
DK2019683T4
(da)
|
2006-04-25 |
2022-08-29 |
Univ California |
Indgivelse af vækstfaktorer til behandling af CNS-lidelser
|
JP2009535360A
(ja)
*
|
2006-04-26 |
2009-10-01 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
高分子量神経治療薬の対流増加送達のための組成物および方法
|
EP1872790A1
(en)
|
2006-06-26 |
2008-01-02 |
DeveloGen Aktiengesellschaft |
New formulation for increasing bioavailability of neurturin
|
US8759297B2
(en)
*
|
2006-08-18 |
2014-06-24 |
Armagen Technologies, Inc. |
Genetically encoded multifunctional compositions bidirectionally transported between peripheral blood and the cns
|
KR100770440B1
(ko)
*
|
2006-08-29 |
2007-10-26 |
삼성전기주식회사 |
질화물 반도체 발광소자
|
US8637459B2
(en)
*
|
2006-11-08 |
2014-01-28 |
Emory University |
Enhancing a population of insulin releasing cells using GFR-A1 agonists
|
CA2685686A1
(en)
|
2007-05-01 |
2008-11-13 |
Biogen Idec Ma Inc. |
Neublastin polypeptides for use increasing vascularization in a tissue
|
US20090011040A1
(en)
*
|
2007-05-02 |
2009-01-08 |
Naash Muna I |
Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases
|
US20200037875A1
(en)
|
2007-05-18 |
2020-02-06 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
WO2008157308A2
(en)
*
|
2007-06-13 |
2008-12-24 |
Wayne State University Board Of Governors |
A zwitterion solution for low-volume therapeutic delivery
|
EP2167071B1
(en)
|
2007-06-13 |
2020-03-18 |
Wayne State University Board Of Governors |
A baclofen solution for low-volume therapeutic delivery
|
EP2182980A4
(en)
|
2007-07-27 |
2012-04-18 |
Armagen Technologies Inc |
METHOD AND COMPOSITIONS FOR INCREASED ALPHA IDURONIDASE ACTIVITY IN THE CNS
|
FI20070808A0
(fi)
|
2007-10-25 |
2007-10-25 |
Mart Saarma |
GDNF:n silmukointivariantit ja niiden käytöt
|
US8417312B2
(en)
|
2007-10-25 |
2013-04-09 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
US9839395B2
(en)
|
2007-12-17 |
2017-12-12 |
Dexcom, Inc. |
Systems and methods for processing sensor data
|
GB0803352D0
(en)
*
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
US20090247856A1
(en)
|
2008-03-28 |
2009-10-01 |
Dexcom, Inc. |
Polymer membranes for continuous analyte sensors
|
FI20080326A0
(fi)
|
2008-04-30 |
2008-04-30 |
Licentia Oy |
Neurotroofinen tekijä MANF ja sen käytöt
|
BRPI0912683A2
(pt)
|
2008-05-15 |
2016-01-26 |
Transmolecular Inc |
tratamento de tumores metastáticos
|
JP6066035B2
(ja)
|
2009-02-12 |
2017-01-25 |
クルナ・インコーポレーテッド |
グリア細胞由来神経栄養因子(gdnf)関連疾病の、gdnfに対する天然アンチセンス転写物の抑制による治療
|
EP2408474B1
(en)
|
2009-03-18 |
2019-06-26 |
Armagen, Inc. |
Compositions and methods for blood-brain barrier delivery of igg-decoy receptor fusion proteins
|
WO2010144696A1
(en)
|
2009-06-11 |
2010-12-16 |
Burnham Institute For Medical Research |
Directed differentiation of stem cells
|
EP3533467B1
(en)
|
2009-10-09 |
2023-07-26 |
Armagen, Inc. |
Methods and compositions for increasing iduronate 2-sulfatase activity in the cns
|
WO2011064437A2
(es)
|
2009-11-26 |
2011-06-03 |
Proyecto De Biomedicina Cima, S.L. |
Vectores virales y procedimientos útiles en la preparación de gdnf
|
EP2531206B1
(en)
|
2010-02-04 |
2017-05-31 |
Morphotek, Inc. |
Chlorotoxin polypeptides and conjugates and uses thereof
|
CN106957356B
(zh)
|
2010-05-11 |
2021-05-25 |
弗雷德哈钦森癌症研究中心 |
氯毒素变体、缀合物及其使用方法
|
CN103502464B
(zh)
|
2010-12-02 |
2016-03-23 |
神经技术美国有限公司 |
分泌抗血管生成抗体支架和可溶性受体的细胞系及其用途
|
UA112981C2
(uk)
|
2011-04-11 |
2016-11-25 |
Елі Ліллі Енд Компані |
Варіант людського gdnf
|
US9549692B2
(en)
|
2011-08-26 |
2017-01-24 |
Dexcom, Inc. |
Polymer membranes for continuous analyte sensors
|
AU2012346448B2
(en)
|
2011-12-02 |
2017-09-14 |
Armagen, Inc. |
Methods and compositions for increasing arylsulfatase A activity in the CNS
|
US9788765B2
(en)
|
2012-09-28 |
2017-10-17 |
Dexcom, Inc. |
Zwitterion surface modifications for continuous sensors
|
RU2015126650A
(ru)
|
2012-12-10 |
2017-01-12 |
Фред Хатчинсон Кэнсер Рисёрч Сентер |
Партнеры липокалина по слиянию
|
WO2014152511A1
(en)
|
2013-03-15 |
2014-09-25 |
The Jackson Laboratory |
Methods for promoting wound healing and hair growth
|
US11559580B1
(en)
|
2013-09-17 |
2023-01-24 |
Blaze Bioscience, Inc. |
Tissue-homing peptide conjugates and methods of use thereof
|
US10369329B2
(en)
|
2014-01-30 |
2019-08-06 |
Renishaw Plc |
Neurosurgical apparatus and method
|
EP3140429B1
(en)
|
2014-05-05 |
2020-02-19 |
Medtronic Inc. |
Methods for scd, crt, crt-d, or sca therapy identification and/or selection
|
US10538589B2
(en)
|
2015-01-14 |
2020-01-21 |
Armagen Inc. |
Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU
|
GB201506052D0
(en)
|
2015-04-09 |
2015-05-27 |
Renishaw Plc |
Movement disorder
|
CA2986769A1
(en)
|
2015-05-27 |
2016-12-01 |
Neurotech Usa, Inc. |
Use of encapsulated cell therapy for treatment of ophthalmic disorders
|
US20170188923A1
(en)
|
2015-12-30 |
2017-07-06 |
Dexcom, Inc. |
Diffusion resistance layer for analyte sensors
|
JP2019535267A
(ja)
|
2016-11-10 |
2019-12-12 |
ケロス セラピューティクス インコーポレイテッドKeros Therapeutics,Inc. |
Gdnf融合ポリペプチド及びその使用方法
|
AU2022238919A1
(en)
|
2021-03-19 |
2023-10-19 |
Dexcom, Inc. |
Drug releasing membrane for analyte sensor
|
WO2023043908A1
(en)
|
2021-09-15 |
2023-03-23 |
Dexcom, Inc. |
Bioactive releasing membrane for analyte sensor
|
CA3228457A1
(en)
|
2022-02-02 |
2023-08-10 |
Dexcom, Inc. |
Sensing systems and methods for diagnosing, staging, treating, and assessing risks of liver disease using monitored analyte data
|
WO2023164584A1
(en)
|
2022-02-23 |
2023-08-31 |
Dexcom, Inc. |
Sensing systems and methods for providing decision support around kidney health and/or diabetes
|
CA3238100A1
(en)
|
2022-06-01 |
2023-12-07 |
Dexcom, Inc. |
Sensing systems and methods for diagnosing kidney disease
|
WO2024050126A2
(en)
|
2022-09-02 |
2024-03-07 |
Dexcom, Inc. |
Continuous analyte sensor devices and methods
|